Primary |
Product Used For Unknown Indication |
55.8% |
Drug Exposure During Pregnancy |
10.5% |
Contraception |
8.1% |
Acute Myeloid Leukaemia |
3.5% |
Diabetes Mellitus |
3.5% |
Myelodysplastic Syndrome |
3.5% |
Exposure During Breast Feeding |
2.3% |
Haemorrhage |
2.3% |
Schizophrenia |
2.3% |
Drug Use For Unknown Indication |
1.2% |
Epilepsy |
1.2% |
Hypertension |
1.2% |
Menorrhagia |
1.2% |
Menstrual Disorder |
1.2% |
Oestrogen Therapy |
1.2% |
Vaginal Haemorrhage |
1.2% |
|
Abortion Spontaneous |
5.0% |
Alanine Aminotransferase Increased |
5.0% |
Breast Feeding |
5.0% |
Death |
5.0% |
Exposure During Breast Feeding |
5.0% |
Headache |
5.0% |
Hepatitis Acute |
5.0% |
Malaise |
5.0% |
Maternal Exposure During Pregnancy |
5.0% |
Mood Altered |
5.0% |
Nausea |
5.0% |
Oedema Peripheral |
5.0% |
Pregnancy On Contraceptive |
5.0% |
Pregnancy On Oral Contraceptive |
5.0% |
Premature Labour |
5.0% |
Product Packaging Quantity Issue |
5.0% |
Rash Pruritic |
5.0% |
Speech Disorder |
5.0% |
Spina Bifida |
5.0% |
Ventricular Septal Defect |
5.0% |
|
Secondary |
Product Used For Unknown Indication |
19.4% |
Idiopathic Thrombocytopenic Purpura |
10.8% |
Haematology Test Abnormal |
9.0% |
Gastrooesophageal Reflux Prophylaxis |
8.8% |
Antiemetic Supportive Care |
8.4% |
Pain |
5.2% |
Hypertension |
5.1% |
Hormone Replacement Therapy |
4.6% |
Blood Cholesterol |
4.5% |
Menstrual Disorder |
4.5% |
Diabetes Mellitus |
4.4% |
Mental Disorder |
4.4% |
Smoking Cessation Therapy |
2.4% |
Endometriosis |
2.1% |
Autoimmune Thrombocytopenia |
1.5% |
Acute Myeloid Leukaemia |
1.4% |
Myelodysplastic Syndrome |
1.2% |
Drug Exposure During Pregnancy |
0.8% |
Drug Use For Unknown Indication |
0.8% |
Menorrhagia |
0.8% |
|
Withdrawal Syndrome |
24.5% |
Vaginal Haemorrhage |
8.8% |
Breast Cancer |
7.5% |
Rectal Haemorrhage |
7.5% |
Purpura |
6.3% |
Rash Maculo-papular |
6.3% |
Haemorrhage |
5.0% |
Breast Cancer Metastatic |
4.4% |
Haemoglobin Decreased |
4.4% |
Rash Erythematous |
4.4% |
Venoocclusive Disease |
3.8% |
Abortion Spontaneous |
3.1% |
Blood Blister |
2.5% |
Melaena |
2.5% |
Arthralgia |
1.9% |
Weight Increased |
1.9% |
Alanine Aminotransferase Increased |
1.3% |
Hepatotoxicity |
1.3% |
Idiopathic Thrombocytopenic Purpura |
1.3% |
Liver Function Test Abnormal |
1.3% |
|
Concomitant |
Product Used For Unknown Indication |
44.7% |
Endometriosis |
13.2% |
Pain |
4.4% |
Prophylaxis |
4.2% |
Prophylaxis Of Nausea And Vomiting |
4.2% |
Contraception |
3.4% |
Hormone Replacement Therapy |
3.3% |
Uterine Leiomyoma |
2.7% |
Drug Use For Unknown Indication |
2.6% |
Rheumatoid Arthritis |
2.2% |
Anxiety |
1.8% |
Haematology Test Abnormal |
1.7% |
Acute Lymphocytic Leukaemia |
1.6% |
Colitis Ulcerative |
1.6% |
Smoking Cessation Therapy |
1.6% |
Asthma |
1.5% |
Hypertension |
1.5% |
Back Pain |
1.4% |
Depression |
1.3% |
Oral Contraception |
1.3% |
|
Hot Flush |
9.7% |
Vaginal Haemorrhage |
9.7% |
Vomiting |
9.1% |
Weight Increased |
7.8% |
Pulmonary Embolism |
5.8% |
Depression |
5.2% |
Weight Decreased |
5.2% |
Migraine |
4.5% |
Nausea |
4.5% |
Urinary Tract Infection |
4.5% |
Anal Cancer |
3.9% |
Muscle Spasms |
3.9% |
Pain |
3.9% |
Rash |
3.9% |
Tonsillitis |
3.9% |
Headache |
3.2% |
Thrombosis |
3.2% |
Abdominal Pain |
2.6% |
Menstruation Irregular |
2.6% |
Proctalgia |
2.6% |
|